Delivery Order SPE2DB22D1103-SPE2DB25FTQE5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,575.97 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections (2.24 mL units). This firm fixed-price contract, awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, was competitively awarded with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Forteo is a FDA-approved medication used to treat...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Forteo 560 MCG/2.24 ML pen injections valued at $7,333.28. This is a firm fixed price delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was not made under any small business set-aside program and was competitively awarded. Forteo is a prescription...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injection) valued at $4,239.43 with a firm fixed price structure. This is a non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency awarded a $13,965.22 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical. The contract will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a $3,666.64 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This is a firm fixed price, non-set-aside contract with a completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a prescription medication used to treat osteoporosis and increase bone density, and this order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections) valued at $14,661.05. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through open competition. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injection) with a ceiling value of $13,586.47 under a Firm Fixed Price contract type. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. Forteo is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,246.43 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections. This competitively awarded, firm fixed-price delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Forteo is a prescription medication used primarily for osteoporosis treatment, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,666.64 to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Forteo is a bone-building medication used to treat osteoporosis in patients at high risk of...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTQE5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Forteo 560 mcg/2.24 mL pen injections with a ceiling value of $2,932.25. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical treatment used primarily for osteoporosis management, reflecting the company's critical role in supplying specialized medications to support federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, supporting customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's continued selection for such awards demonstrates its capability to meet federal procurement requirements through competitive competition and its established position as a major pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 6/20/25 |